Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China.
Adolescent
Adult
Aged
Angiotensin-Converting Enzyme 2
Betacoronavirus
/ genetics
Biomarkers
/ metabolism
COVID-19
COVID-19 Testing
China
Clinical Laboratory Techniques
Coronavirus Infections
/ diagnosis
Cough
/ diagnosis
Female
Fever
/ diagnosis
Gene Expression
Humans
Infectious Disease Incubation Period
Male
Middle Aged
Pandemics
Peptidyl-Dipeptidase A
/ genetics
Pharyngitis
/ diagnosis
Pneumonia, Viral
/ diagnosis
Prognosis
Real-Time Polymerase Chain Reaction
Retrospective Studies
SARS-CoV-2
Severity of Illness Index
Survival Analysis
Tomography, X-Ray Computed
ACE2
Clinical characteristics
Coronavirus disease-19 (COVID-19)
Huanggang
Novel coronavirus pneumonia
Taian
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
10
03
2020
accepted:
04
05
2020
pubmed:
12
5
2020
medline:
8
10
2020
entrez:
12
5
2020
Statut:
ppublish
Résumé
We aimed to report the clinical characteristics of 194 cases coronavirus disease-19 (COVID-19) in Huanggang, Hubei and Taian, Shandong. We retrospectively investigated the clinical, laboratory characteristics and CT imaging of confirmed cases of COVID-19 from January 22 to February 28, 2020 in Huanggang Central Hospital and The Second Affiliated Hospital of Shandong First Medical University. Real time PCR was used to detect the new coronavirus in respiratory samples. Immunohistochemical staining was used to detect the expressions of ACE2 in tissues. Among the 194 patients infected with COVID-19, 108 patients were male, with a median age of 48.3 years. The average preclinical period was 7.44 day. Except for 37 severe or critically ill patients, the rest of the 157 patients exhibited mild or moderate symptoms. 190 (97.94%) patients were confirmed during the three times nucleic acid test. The main clinical symptom of the patients were fever, sore throat and cough, which accounted for 146 cases (75.26%), 98 (50.52%) and 86 cases (44.33%), respectively. 30 patients (15.46%) showed liver dysfunction. Imaging examination showed that 141 patients (72.68%) showed abnormal density shadow, while 53 cases (27.32%) had no obvious abnormality in the parenchyma of both lungs. Up to now, 109 cases have been discharged from the hospital, and 9 patients died. The ACE2 expression levels were up-regulated in patients of severe type and critically ill type. Clinical symptoms, laboratory tests and CT imaging should be combined for comprehensive analysis to diagnose COVID-19. ACE2 may be the receptor of COVID-19.
Identifiants
pubmed: 32390091
doi: 10.1007/s15010-020-01440-5
pii: 10.1007/s15010-020-01440-5
pmc: PMC7211492
doi:
Substances chimiques
Biomarkers
0
Peptidyl-Dipeptidase A
EC 3.4.15.1
ACE2 protein, human
EC 3.4.17.23
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
687-694Subventions
Organisme : The Project of COVID-19 of Taian, Shandong Province
ID : COVID-19-2020
Références
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
J Clin Med. 2020 Feb 29;9(3):
pubmed: 32121356
J Infect. 2020 Apr;80(4):388-393
pubmed: 32112884
J Pathol. 2003 Jul;200(3):282-9
pubmed: 12845623
J Korean Med Sci. 2020 Feb 17;35(6):e79
pubmed: 32056407
Int J Epidemiol. 2004 Aug;33(4):628-34
pubmed: 15155694
Adv Virus Res. 2011;81:85-164
pubmed: 22094080
J Infect. 2020 May;80(5):578-606
pubmed: 32119884
J Infect. 2020 Apr;80(4):401-406
pubmed: 32112886
Chest. 2020 Apr;157(4):e99-e101
pubmed: 32087216
Nat Med. 2005 Aug;11(8):875-9
pubmed: 16007097
J Infect. 2020 Apr;80(4):394-400
pubmed: 32109443
Clin Infect Dis. 2020 Jul 28;71(15):706-712
pubmed: 32109279
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
N Engl J Med. 2003 May 15;348(20):1986-94
pubmed: 12682352
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 05;43(0):E004
pubmed: 32023687
Int J Infect Dis. 2020 Mar;92:214-217
pubmed: 32007643
World J Pediatr. 2020 Jun;16(3):240-246
pubmed: 32026148
Lancet. 2020 Feb 22;395(10224):542-545
pubmed: 32061313
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651